Prana Biotechnology will be presenting at the China Healthcare Investment & Partnering Symposium on Saturday 17 March 2018 at 9.30am China Standard Time. Please access the webcast via the following link: http://wsw.com/webcast/brileyco20/pran/ The webcast will be archived for 90 days following the presentation.
Author: Kerry Rowe
Dr. David Stamler will be presenting at the China Healthcare Investment & Partnering Symposium on Saturday 17 March 2018 at 9.30am China Standard Time.
Prana’s PBT434 prevents neuronal loss in a new model of neurodegeneration
Prana Biotechnology JPM investor presentation_updated
Dr. David Stamler presenting at Biotech Showcase
Prana has today announced that is has received a A$3.02 million cash refund under the Australian Government’s R&D Tax Incentive Scheme.
AGM Presentation 2017
Prana Biotechnology invites investors unable to attend the Annual General Meeting to participate via teleconference.
Prana has announced that it has filed its Annual Report on Form 20-F
PBT434, Prana’s lead drug in preclinical development for movement disorders, to be profiled in collaborative venture